 combin hormon therapi tamoxifen fluoxymesteron versu tamoxifen postmenopaus women metastat breast cancer updat analysi random trial therapi tamoxifen tam fluoxymesteron flu efficaci tam postmenopaus women metastat breast cancer patient tam flu dose drug mg twice object respons patient tam flu patient two-sid time progress tam flu median month cox model durat respons surviv similar treatment arm patient estrogen receptor ER year age signific advantag treatment tam flu respons rate time progress particular note patient group tam flu surviv advantag cox model data confirm prospect trial substant therapeut advantag tam flu tam elderli women ER fmol